European Union underinvestment in endometriosis research
This study found that European Union funding for endometriosis research from 2003 to 2023 was limited, totaling approximately 15 million euros for ten specific projects, with a focus on diagnostics over etiopathogenesis and treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables via openalex
- Endometriosis and IVF treatment outcomes: unpacking the process via openalex
- Genomic characterisation of the overlap of endometriosis with 76 comorbidities identifies pleiotropic and causal mechanisms underlying disease risk via openalex
- “I’m looking through you”: What consumers and manufacturers need to know about non-invasive diagnostic tests for endometriosis via openalex
- Multicenter evaluation of blood‐based biomarkers for the detection of endometriosis and adenomyosis: A prospective non‐interventional study via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions via openalex
- Proposal for targeted, neo-evolutionary-oriented, secondary prevention of early-onset endometriosis and adenomyosis. Part I: pathogenic aspects via openalex
- Surgery versus IVF for the treatment of infertility associated to ovarian and deep endometriosis (SVIDOE: Surgery Versus IVF for Deep and Ovarian Endometriosis). Clinical protocol for a multicenter randomized controlled trial via openalex
- The Burden of Endometriosis on Women’s Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing via openalex
- “The sound of silence” Giving voice to endometriosis-related positional dyspareunia via openalex
- W6858188216 via openalex
- W4214754424 via openalex
- W4234160457 via openalex
- W4280645308 via openalex
- W4367843757 via openalex
- W4383955551 via openalex
- W4385330952 via openalex
- W6838640230 via openalex
- W6846860059 via openalex
- W6855463481 via openalex
- W6857738132 via openalex
Cited by (5)
- The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets 2026
- Assessing healthcare needs in endometriosis: a scoping review 2025
- Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
- “Ladies first”: a plea for prioritizing women’s inclusion in the research and health care agenda 2024
- Understanding endometriosis underfunding and its detrimental impact on awareness and research 2024
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00